In today's rapidly changing and highly competitive business world, it is vital for investors and industry enthusiasts to carefully assess companies. In this article, we will perform a comprehensive industry comparison, evaluating Merck & Co (NYSE:MRK) against its key competitors in the Pharmaceuticals industry. By analyzing important financial metrics, market position, and growth prospects, we aim to provide valuable insights for investors and shed light on company's performance within the industry.
Merck & Co Background
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Company | P/E | P/B | P/S | ROE | EBITDA (in billions) | Gross Profit (in billions) | Revenue Growth |
---|---|---|---|---|---|---|---|
Merck & Co Inc | 921.64 | 8.70 | 5.47 | -3.11% | $-0.77 | $10.72 | 5.78% |
Eli Lilly and Co | 131.90 | 67.48 | 20.25 | 19.91% | $3.03 | $7.57 | 28.1% |
Novo Nordisk A/S | 45.23 | 35.27 | 16.30 | 22.01% | $28.51 | $55.85 | 36.95% |
Johnson & Johnson | 30.96 | 5.64 | 4.84 | 5.78% | $6.82 | $14.6 | 7.3% |
Novartis AG | 25.16 | 4.52 | 4.62 | 19.99% | $4.18 | $8.75 | 7.39% |
AstraZeneca PLC | 34.82 | 5.25 | 4.52 | 2.52% | $2.18 | $9.72 | 7.29% |
Pfizer Inc | 72.68 | 1.71 | 2.59 | -3.62% | $-1.77 | $6.69 | -41.34% |
Sanofi SA | 20.73 | 1.50 | 2.41 | -0.75% | $0.42 | $8.15 | 6.5% |
Bristol-Myers Squibb Co | 13.09 | 3.47 | 2.33 | 6.03% | $4.45 | $8.73 | 0.62% |
Zoetis Inc | 39.25 | 18.23 | 10.77 | 10.42% | $0.83 | $1.49 | 8.48% |
GSK PLC | 13.95 | 5.08 | 2.27 | 2.64% | $1.78 | $5.63 | -1.17% |
Takeda Pharmaceutical Co Ltd | 39.72 | 1.04 | 1.69 | -0.69% | $202.28 | $699.51 | 4.07% |
Viatris Inc | 8.76 | 0.76 | 1.03 | 1.59% | $1.22 | $1.69 | -3.34% |
Dr Reddy's Laboratories Ltd | 20.33 | 3.96 | 3.91 | 5.29% | $22.42 | $42.2 | 6.57% |
Jazz Pharmaceuticals PLC | 159.39 | 2.39 | 2.43 | 4.19% | $0.33 | $0.87 | 3.35% |
Average | 46.86 | 11.16 | 5.71 | 6.81% | $19.76 | $62.25 | 5.05% |